2-[(2,6-dichloro-3-methyl-phenyl)amino]benzoic acid

JMS as a free ligand exists in 5 entries. Examples include: 5IKQ 4N6P 4QKN

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo

Chemical Component Summary

Name2-[(2,6-dichloro-3-methyl-phenyl)amino]benzoic acid
Identifiers2-[(2,6-dichloro-3-methyl-phenyl)amino]benzoic acid
FormulaC14 H11 Cl2 N O2
Molecular Weight296.15
Isomeric SMILESCc1ccc(Cl)c(Nc2ccccc2C(O)=O)c1Cl

Chemical Details

Formal Charge0
Atom Count30
Chiral Atom Count0
Chiral Atomsn/a
Bond Count31
Aromatic Bond Count12
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB00939 Different stereochemistry
NameMeclofenamic acid
  • approved
  • vet_approved
DescriptionA non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis. [PubChem]
  • Acide meclofenamique
  • Acido meclofenamico
  • Acidum meclofenamicum
  • CI-583
  • INF 4668
SaltsMeclofenamate sodium
Brand Names
  • Meclofenamate Sodium
  • Ethos
  • Eucome
  • Meclomen
Affected OrganismHumans and other mammals
IndicationFor the relief of mild to moderate pain, for the treatment of primary dysmenorrhea and for the treatment of idiopathic heavy menstrual blood loss. Also for relief of the signs and symptoms of acute and chronic rheumatoid arthritis and osteoarthritis.
PharmacologyMeclofenamic acid is a nonsteroidal agent which has demonstrated anti-inflammatory, analgesic, and antipyretic activity in laboratory animals.
Mechanism of actionThe mode of action, like that of other nonsteroidal anti-inflammatory agents, is not known. Therapeutic action does not result from pituitary-adrenal stimulation. In animal studies, meclofenamic acid was found to inhibit prostaglandin synthesis and to compete for binding at the prostaglandin receptor site. In vitro meclofenamic acid was found to be an inhibitor of human leukocyte 5-lipoxygenase activity. These properties may be responsible for the anti-inflammatory action of meclofenamic acid. There is no evidence that meclofenamic acid alters the course of the underlying disease.
Route of administrationOral
  • Acids, Carbocyclic
  • Amines
  • Aminobenzoates
  • Analgesics
  • Analgesics, Non-Narcotic
  • M01AG04
  • M02AA18
CAS number644-62-2
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682